Oral Anticoagulants Market Outlook, Demand, Growth, Top Key Players and Forecast to 2030

[vaibhav]

Oral Anticoagulants Market

The Oral Anticoagulants Market Share is expected to reach USD 37,617.33 Million by 2030 at 8.90% CAGR during the forecast period 2022-2030.

Anticoagulant is a drug, when added to blood, prevents it from clotting. Anticoagulants achieve their effect by suppressing the synthesis or function of various clotting factors that are normally present in the blood. Such drugs are often used to prevent the formation of blood clots (thrombi) in the veins or arteries or the enlargement of a clot that is circulating in the bloodstream.

Increasing cardiovascular disorders, rising geriatric population, and increasing surgical procedures support the growth of the global oral anticoagulants market in recent years. However, the high cost is likely to restrain market growth over the forecast period.

Oral Anticoagulants Market Outlook and Analysis by Product (Novel Oral Anticoagulant and Warfarin), By Disease Indication (Atrial Fibrillation, Deep Vein Thrombosis/ Pulmonary Embolism), By Distribution Channel (Hospital Pharmacies) - Forecast till 2030

Major Key Players:

Market Research Future (MRFR) recognizes the Key Market Players are AstraZeneca, Plc (UK), Pfizer (US), Boehringer Ingelheim GmbH (Germany), Daiichi Sankyo Company Ltd (Japan), Abbott Laboratories (US), Eli Lilly and Company (US), GlaxoSmithKline plc (UK) Portola Pharmaceuticals Inc. (US), Medicure (Canada), Johnson & Johnson Services Inc. (US), and others.

Segment Analysis

The global oral anticoagulants market, as reported by MRFR, has been segmented into disease indication, product, and distribution channel. These segmental studies of the market reveal better insights that can help in devising strategies of diverse types to ensure better profits for the coming years.

By product, the global study on the oral anticoagulant market provides an in-depth study on the basis of a novel oral anticoagulant and warfarin. The warfarin segment is getting a good thrust. 

By disease indication, the report on the global oral anticoagulants market has been segmented into deep vein thrombosis/ pulmonary embolism, atrial fibrillation (AF)/ stroke prevention, and others. The global atrial fibrillation/ stroke prevention segment is getting good traction due to a rise in the reporting of such conditions. These trigger a better demand for oral anticoagulants. 

By distribution channel, the discussion on the global oral anticoagulants market includes retail pharmacies, hospital pharmacies, and E-commerce. The e-commerce segment is expected to grow fast due to the growing acceptance of the system to have hassle-free deliveries. The retail pharmacies segment would also make a substantial move forward. 

Regional Analysis

The Americas, as a market, is expected to show better growth possibilities. Already, the region has countries like the US and Canada from, the northern part and Argentina, Brazil, Colombia, and Chile from the southern part that are known for their extensive market contributions. North America has a better market structure in the healthcare department and is witnessing more people taking part in the regional market growth. Increasing number of surgeries and other procedures are triggering the intake of oral anticoagulant drugs. In Europe, the market is finding similar growth in regions like Germany, France, Spain, Italy, the UK, Denmark, Sweden, and other countries. Their healthcare structure is quite extensive and supports various policies that would ensure better market percolation for oral anticoagulant drugs. The regional market is all set fetch high revenues. In the Asia Pacific region, the integration of top-grade health care equipment is expected to create a better space for the oral anticoagulants market to expand.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

[phone]

Email: [e-mail]